InsidersTradesSigma
Follow the NURIX THERAPEUTICS INC share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on US US, under the oversight of SEC (Form 4). The latest transaction was disclosed on 25 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: GWENN M HANSEN. Every trade is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
NURIX THERAPEUTICS INC is a biopharmaceutical company focused on developing innovative therapies based on protein degradation. It is listed on NASDAQ under the symbol NRIX.